Louis R Pasquale - Ophthalmology (Eye)

Biography

Specialties

Ophthalmology (Eye), Glaucoma

Education

MD, State University of NY at Stony Brook School of Medicine

Internship, Internal Medicine, Albert Einstein College of Medicine-Yeshiva University

Residency, Ophthalmology, Temple University Hospital-Episcopal Division

Fellowship, Glaucoma, Wilmer Eye Institute-Johns Hopkins University

Certifications

American Board of Ophthalmology

Publications

309

Publications

Selected Publications

A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery. Ron D. Hays, Michelle E. Tarver, Malvina Eydelman, George L. Spaeth, David W. Parke, Kuldev Singh, Don Nguyen, Robert M. Saltzmann, Oluwatosin Smith, My Le Shaw, Lisa Rosenberg, Leo Seibold, Savak Teymoorian, Lorraine M. Provencher, Amanda K. Bicket, Nitika Arora, Anna K. Junk, Craig Chaya, Sarwat Salim, Debbie Kuo, Asher Weiner, Ze Zhang, Brian Francis Douglas Rhee, Brian McMillan, Clara Choo, Winston Garris, Rob Noecker, Ronald Fellman, Joseph Caprioli, Steven Vold, Louis Pasquale, Qi Cui, Michael Mbagwu. American Journal of Ophthalmology

Using Multi-Layer Perceptron Driven Diagnosis to Compare Biomarkers for Primary Open Angle Glaucoma. Nicholas Riina, Alon Harris, Brent A. Siesky, Lukas Ritzer, Louis R. Pasquale, James C. Tsai, James Keller, Barbara Wirostko, Julia Arciero, Brendan Fry, George Eckert, Alice Verticchio Vercellin, Gal Antman, Paul A. Sidoti, Giovanna Guidoboni. Investigative Ophthalmology and Visual Science

Glucagon-Like Peptide 1 Receptor Agonists: A Role in Glaucoma?. Catherine Johnson, Louis R. Pasquale, Barbara Wirostko. Ophthalmology Glaucoma

View All Publications

Video

Louis Pasquale, MD: Future Is Bright for Glaucoma Patients

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Pasquale during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Twenty Twenty

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Pasquale during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Twenty Twenty

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.